We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
Cap. Flow
+$469M
Cap. Flow %
8.38%
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 15.15%
3 Healthcare 14.96%
4 Consumer Discretionary 10.52%
5 Industrials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FALC
976
DELISTED
FalconStor Software Inc
FALC
$74K ﹤0.01%
+71,406
New +$74.7K
TNXP icon
977
Tonix Pharmaceuticals
TNXP
$157M
0
VIRX
978
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$72K ﹤0.01%
469
-944
-67% -$133K
AKAO
979
DELISTED
Achaogen Inc
AKAO
$72K ﹤0.01%
15,019
-47,553
-76% -$190K
CLD
980
DELISTED
Cloud Peak Energy Inc
CLD
$70K ﹤0.01%
12,898
-900
-7% -$3.13K
OESX icon
981
Orion Energy Systems
OESX
$41.1M
$69K ﹤0.01%
5,177
-2,900
-36% -$38.8K
EVRI
982
DELISTED
Everi Holdings
EVRI
$67K ﹤0.01%
27,200
+17,100
+169% +$34K
EGAN icon
983
eGain
EGAN
$176M
$66K ﹤0.01%
+21,405
New +$60.5K
PLUR icon
984
Pluri
PLUR
$19.2M
$64K ﹤0.01%
498
+109
+28% +$13.7K
ENPH icon
985
Enphase Energy
ENPH
$4.84B
$63K ﹤0.01%
53,394
FCSC
986
DELISTED
Fibrocell Science Inc.
FCSC
$61K ﹤0.01%
5,629
-6,558
-54% -$97.3K
SUNE
987
SUNation Energy
SUNE
$9.9M
0
EGY icon
988
Vaalco Energy
EGY
$594M
$58K ﹤0.01%
62,165
CPIX icon
989
Cumberland Pharmaceuticals
CPIX
$99M
$57K ﹤0.01%
11,450
-2,600
-19% -$12.2K
CALA
990
DELISTED
Calithera Biosciences, Inc
CALA
$54K ﹤0.01%
828
ONCT
991
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$49K ﹤0.01%
45
XOMA
992
DELISTED
Xoma
XOMA
$41K ﹤0.01%
4,455
-16,351
-79% -$188K
LTS
993
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$34K ﹤0.01%
14,933
-2,867
-16% -$6.67K
WSTL
994
DELISTED
Westell Technologies Inc
WSTL
$33K ﹤0.01%
16,256
-925
-5% -$2.26K
IMN
995
DELISTED
Imation
IMN
$33K ﹤0.01%
52,108
-49,219
-49% -$47.7K
TST
996
DELISTED
TheStreet, Inc.
TST
$27K ﹤0.01%
2,460
CBK
997
DELISTED
Christopher & Banks Corporation
CBK
$26K ﹤0.01%
17,630
-55,938
-76% -$101K
DZSI
998
DELISTED
DZS Inc. Common Stock
DZSI
$24K ﹤0.01%
4,250
-15,797
-79% -$90.5K
ATHX
999
DELISTED
Athersys, Inc. Common Stock
ATHX
$23K ﹤0.01%
435
-7,059
-94% -$365K
WYY icon
1000
WidePoint Corp
WYY
$104M
$9K ﹤0.01%
+2,055
New +$10.8K

Similar funds

Jacobs Levy Equity Management's Q3 2016 Portfolio in Review

As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
  • Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
  • Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
  • Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
  • Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
  • Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.